Correlation Between MA Financial and Bio Gene

Can any of the company-specific risk be diversified away by investing in both MA Financial and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MA Financial and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MA Financial Group and Bio Gene Technology, you can compare the effects of market volatilities on MA Financial and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MA Financial with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of MA Financial and Bio Gene.

Diversification Opportunities for MA Financial and Bio Gene

0.08

Correlation Coefficient

MA Financial  Bio Gene

Significant diversification

The 3 months correlation between MAF and Bio is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding MA Financial Group and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and MA Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MA Financial Group are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of MA Financial i.e., MA Financial and Bio Gene go up and down completely randomly.

Pair Corralation between MA Financial and Bio Gene

Assuming the 90 days trading horizon MA Financial Group is expected to generate 0.41 times more return on investment than Bio Gene. However, MA Financial Group is 2.42 times less risky than Bio Gene. It trades about 0.01 of its potential returns per unit of risk. Bio Gene Technology is currently generating about -0.11 per unit of risk. If you would invest  601.00  in MA Financial Group on September 13, 2024 and sell it today you would lose (1.00) from holding MA Financial Group or give up 0.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

MA Financial Group  vs.  Bio Gene Technology

MA Financial Group

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in MA Financial Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, MA Financial unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with MA Financial and Bio Gene

The main advantage of trading using opposite MA Financial and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MA Financial position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.

The idea behind MA Financial Group and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.